These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 2352978

  • 1. Therapy of homozygous type IIA familial hypercholesterolemia using special on line plasma filter pheresis.
    Siami G, Hakim R.
    Prog Clin Biol Res; 1990; 337():209-12. PubMed ID: 2352978
    [No Abstract] [Full Text] [Related]

  • 2. Thermofiltration in hypercholesterolemia: analysis of removal and posttreatment cholesterol recovery.
    Malchesky PS, Nomura H, Werynski A, Takeyama Y, Yamashita M, Nosè Y.
    Prog Clin Biol Res; 1990; 337():201-4. PubMed ID: 2352977
    [No Abstract] [Full Text] [Related]

  • 3. Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia.
    Fernández-Fuertes LF, Tapia Martín M, Nieves Plá I, Novoa Mogollón FJ, Díaz Cremades J.
    Ther Apher Dial; 2010 Oct; 14(5):484-5. PubMed ID: 21175548
    [No Abstract] [Full Text] [Related]

  • 4. [Familial homozygotic infantile hypercholesterolemia treated with lipoprotein apheresis during a year].
    Teruel Briones JL, Lasunción Ripa MA, Gallego Cobos N, Castañón Rodríguez MA, Ortuño Mirete J.
    An Esp Pediatr; 1993 Aug; 39(2):159-62. PubMed ID: 8239213
    [No Abstract] [Full Text] [Related]

  • 5. [An apheresis method in treatment of familial hypercholesterolemia].
    Derfler K.
    Wien Klin Wochenschr; 2000 Jan 28; 112(2):49-51. PubMed ID: 10703150
    [No Abstract] [Full Text] [Related]

  • 6. LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia.
    Nenseter MS, Bogsrud MP, Græsdal A, Narverud I, Halvorsen B, Ose L, Aukrust P, Holven KB.
    Thromb Res; 2012 Nov 28; 130(5):823-5. PubMed ID: 22728023
    [No Abstract] [Full Text] [Related]

  • 7. [A case with homozygote familial hypercholesterolemia treated with LDL apheresis and coronary bypass in adolescence period].
    Altinel E, Cetinkaya S, Kara C, Orün UA, Aydin H, Kutsal A.
    Anadolu Kardiyol Derg; 2008 Jun 28; 8(3):231-2. PubMed ID: 18524734
    [No Abstract] [Full Text] [Related]

  • 8. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
    Dairou F, Rottembourg J, Truffert J, Assogba U, Bruckert E, de Gennes JL, Jacobs C.
    Beitr Infusionsther; 1988 Jun 28; 23():152-9. PubMed ID: 2484771
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption system.
    Yamamoto A, Yokoyama S, Satani M, Kikkawa T, Kishino B.
    Prog Clin Biol Res; 1988 Jun 28; 255():357-66. PubMed ID: 3340645
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis.
    Riesen WF, Sturzenegger E, Imhof C, Descoeudres C, Mordasini R, Oetliker OH.
    Prog Clin Biol Res; 1988 Jun 28; 255():337-46. PubMed ID: 3422496
    [No Abstract] [Full Text] [Related]

  • 11. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
    Mol MJ, Stalenhoef AF.
    Neth J Med; 1990 Jun 28; 36(5-6):279-87. PubMed ID: 2395495
    [Abstract] [Full Text] [Related]

  • 12. Plasma-exchange therapy of homozygous familial hypercholesterolemia.
    King ME, Breslow JL, Lees RS.
    N Engl J Med; 1980 Jun 26; 302(26):1457-9. PubMed ID: 7374711
    [No Abstract] [Full Text] [Related]

  • 13. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
    Jansen M, Banyai S, Schmaldienst S, Goldammer A, Rohac M, Hörl WH, Derfler K.
    Wien Klin Wochenschr; 2000 Jan 28; 112(2):61-9. PubMed ID: 10703153
    [Abstract] [Full Text] [Related]

  • 14. Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis.
    Mabuchi H, Michishita I, Sakai T, Sakai Y, Watanabe A, Wakasugi T, Takeda R.
    Atherosclerosis; 1986 Aug 28; 61(2):135-40. PubMed ID: 3463306
    [Abstract] [Full Text] [Related]

  • 15. Regression of atherosclerosis in patients with familial hypercholesterolaemia under LDL-apheresis.
    Borberg H, Gaczkowski A, Hombach V, Oette K, Stoffel W.
    Prog Clin Biol Res; 1988 Aug 28; 255():317-26. PubMed ID: 3340643
    [No Abstract] [Full Text] [Related]

  • 16. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.
    Coker M, Ucar SK, Simsek DG, Darcan S, Bak M, Can S.
    Ther Apher Dial; 2009 Apr 28; 13(2):121-8. PubMed ID: 19379151
    [Abstract] [Full Text] [Related]

  • 17. [Radical therapy of refractory hyperlipidemia: extracorporeal cholesterol elimination].
    Kostner KM.
    Wien Med Wochenschr; 1994 Apr 28; 144(12-13):333-5. PubMed ID: 8650940
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS, Katz J, Ross J, Rader DJ.
    J Clin Apher; 2005 Dec 28; 20(4):252-5. PubMed ID: 15880364
    [Abstract] [Full Text] [Related]

  • 19. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject.
    Ketomaki A, Gylling H, Miettinen TA.
    J Lab Clin Med; 2004 Apr 28; 143(4):255-62. PubMed ID: 15085084
    [Abstract] [Full Text] [Related]

  • 20. [Changes of erythrocyte and lymphocyte membrane fluidity after plasma extraction in children with type II homozygous hypercholesterolemia].
    Motta C, Palcoux JB, Meyer M, Roche M.
    Ann Med Interne (Paris); 1988 Apr 28; 139 Suppl 1():83-5. PubMed ID: 3247997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.